作者: Hanno Richards , Brian Porter , Christian Mann
DOI:
关键词:
摘要: The present disclosure relates to methods for treating non-radiographic axial spondyloarthritis (nr-axSpA) patients and inhibiting the progression of structural damage in these patients, using IL-17 antagonists, e.g., secukinumab. Also disclosed herein are uses antibodies, such as secukinumab, nr-axSpA well medicaments, dosing regimens, pharmaceutical formulations, dosage forms, kits use methods.